Pharmaceutical promotion and transfer-pricing comparability principles limited disallowances, while uncorroborated search allegations and unsupported ...
Business expenditure substantiation supports scrap credits, statutory payments and expense claims, while depreciation requires proof of actual busines...
Addition u/s 56(2)(viib) - shares being issued at excessive rate - When shares are issued at a premium by a subsidiary to its holding company, based on a recognized valuation method like the Discounted Cash Flow, additions under Section 56(2)(viib) are not justified unless there is evidence of unaccounted money or manipulation. - AT
Addition u/s 56(2)(viib) - shares being issued at excessive rate - When shares are issued at a premium by a subsidiary to its holding company, based on a recognized valuation method like the Discounted Cash Flow, additions under Section 56(2)(viib) are not justified unless there is evidence of unaccounted money or manipulation. - AT
Note: It is a system-generated summary and is for quick reference only.